The lawsuit filers include two licensed doctors, one M.D./Ph.D., one other scientist, an engineer, and a statistician, all of whom sat on scientific review committees for the Center for Devices and Radiological Health, which judges the efficacy of cancer-screening devices. The lawsuit alleges that senior FDA officials approved certain devices despite poor scientific reviews. The lawsuit mentions just a few devices—most prominently, one for colon cancer and one for breast cancer—but the complaints stretch to more than 10 different devices overall, says Stephen Kohn, the lead counsel for the filers and the director of the National Whistleblowers Center. Kohn added that in at least one case, officials pressured an engineer to change the warning labels on a device, removing negative language. (The FDA declined to comment on any aspect of the allegations because the lawsuit is pending.)
Abexome’s primary business objective is to provide core biology services to the Pharmaceutical Industry and to the Academic Labs and also to develop immunological reagents for use in
Life Science
Research and in Clinical Diagnostics. Currently Abexome in engaged with a large number of pharmaceutical and biotech companies and academic labs in the country for providing services like recombinant protein development, custom antibody development and assay development. Abexome’s antibody products are used by a number of customers in India.
The Drug War's Invisible Victims
There are also war tolls beyond the body counts. The homicide number
misses the disappeared, the thousands whose bodies – dead or alive – are never found, never counted. And it hides the mutilation of lives caused by “collateral damage”: the loss of loved ones, families forced from their homes, permanent injury, orphans and widows, sexual abuse, lives lived in fear.
These costs fall primarily on the shoulders of women–the mothers, daughters, and sisters who are left with the nearly impossible task of seeking answers and redress in a justice system outpaced by violence and overrun by corruption. They are often re-victimized by government agencies that ignore, reject, or stifle their pleas for justice.
Read the full article at:
CIP Americas
North America
Pot-based Prescription Drugs Are On Their Way
A British company, GW Pharma, is in advanced clinical trials for the world's first pharmaceutical developed from raw marijuana instead of synthetic equivalents — a mouth spray it hopes to market in the U.S. as a treatment for cancer pain. It hopes to see FDA approval by the end of 2013.
Sativex contains marijuana's two best known components — delta 9-THC and cannabidiol — and already has been approved in Canada, New Zealand and eight European countries for relieving muscle spasms associated with multiple sclerosis.
Read the full article at:
Seattle Times
Welfare Drug-testing Bill Passes Indiana House
Rep. McMillin
withdrew his bill on Friday, saying
Dvorak's amendment likely violated the Constitution. On Monday, he came back with a new version of the legislation that softened the lawmaker drug testing provision. Instead of blanket testing for every member of the General Assembly, the new version of the bill lets lawmakers opt in to a system of random screening similar to the one for families seeking cash assistance. (If they don't consent, they lose their parking spaces and other perks.)
Read the full article at:
Huffington Post
Critics Counter County's Claim of Ecstasy Epidemic
If anything, Sibley says, it’s the drugs that aren’t MDMA or ecstasy that can do the most damage. MDMA, colloquially referred to as Molly, often comes in through black-market shipments of pills or capsules containing powder, Sibley says, which can lead to the drugs being cut with methamphetamine, ketamine, benzopiprozene (BZP), or dextromethorphan (DXM).
According to county figures, five people have died from taking drugs they thought were ecstasy since 2009.
“The frightening thing, when you look at it, is that so few of them actually contain [MDMA],” Sibley says. Of the tablets seized by law enforcement, Sibley estimates that as few as one in four may actually contain MDMA.
Read the full article at:
SanJose.com
Europe/UK
Is Banning Legal Highs Effective? Learning From the Hungarian Experience
This current epidemic of legal highs was partly caused by the collapse of the European Ecstasy (MDMA) market in 2008. That is, the (at least temporarily) successful efforts of our politicians to prevent the large scale production of MDMA led to the rise of new legal substitutes to fill the gap in the recreational stimulant market. So now, instead of one relatively less harmful substance (MDMA) dominating the night life we have many new substances with unknown risks and harms. Governments try to respond the crisis of prohibition with more prohibition: restrict drug legislation and prohibit new substances as fast as they can.
Read the full editorial at:
European Drug Policy Initiative
Fixerum: The Mobile Injection Room in Copenhagen
Most injecting drug users has been using drugs in dark alleys where there is no access to sterile injection equipment and nobody helps if they overdose - but this situation is changing now. Harm reduction activists were tired of many years of debate so they went ahead and set up a new mobile injection room, Fixerum. This van aims to reach out people who use drugs on the streets and let them use drugs under medial supervision.
Read the full article accompanying the video at:
International Drug Policy Consortium (IDPC)
Drugs Mule Terms Cut in New Sentencing Guidelines
Under the new guideline, which comes into force on 27 February, the starting point for sentencing drug mules guilty of carrying crack, heroin and cocaine will be six years, before judges take into account aggravating and mitigating factors.
Those found guilty of a much higher level of involvement in the drugs trade will face longer sentences.
Read the full article at:
BBC News
Latin America
The State of Mexico's Major Cartels
Global intelligence organization STRATFOR released its annual analysis of the state of the Mexican drug cartels, and forecasts their activities in 2012. It's a comprehensive primer for anyone interested in the narco-war and its social and political implications for the violence-plagued country.
Read the full report at:
The Cutting Edge News
Organized Crime Sets Its Sights on Peaceful Uruguay
While the scale of drug trafficking in Uruguay is nowhere near that which exists in Mexico, its remote borders with Argentina and Brazil and its 600 kilometer-long coast make the country a significant transshipment point for foreign drug smugglers. A comparison could be drawn with
Ecuador, which is used by criminal groups of various nationalities
, drawn by its convenient location bordering Colombia and Peru.
Read the full article at:
InSight
Other News
The Neuroscience of Pot: Why Marijuana May Bring Serenity or Psychosis
In the
new study
, the researchers had 15 men who were relatively unseasoned pot users take capsules containing THC, CBD, and flour (placebo) on each of three occasions. The participants then took simple computer tests in which arrows, pointing either left or right, flashed on the screen; the men had to respond based on their direction. Occasionally, an “oddball” arrow was thrown in to the sequence, which was at a 23-degree angle. This setup allowed the researchers to compare the men’s reactions to usual vs. oddball stimuli, and to see how the various chemicals affected it.
Read the full article at:
Forbes
Jean Marlowe is known as the Godmother of Medical Cannabis in the State of North Carolina. In this wildly entertaining interview, the feisty Marlowe gives her irreverent take on the hypocrisy of cannabis prohibition, and gives moving testimony about the damage done to medical patients caught up in the criminal justice system.
The Exile Nation Project - Interview with Jean Marlowe from
Charles B Shaw on
Vimeo.
Newsletters and Weekly Features
http://www.expert-reviews.com/doi/abs/10.1586/14737175.6.9.1249 (excerpt follows)
Foley KF,
DeSanty KP,
Kast RE,
Expert Rev Neurother, 2006 Sep;6(9):1249-65, U VT, Dept of Medical Lab and Radiation Sciences Burlington
Anecdotal reports indicate bupropion may lower inflammatory mediators such as tumor necrosis factor-alpha, may lower fatigue in cancer and may help reduce concentration problems.
More than 3,000 academics, including several Fields medal-winning mathematicians, have put their names to a petition declaring their intention to boycott the academic publisher
Elsevier.
The
"Cost of Knowledge" petition claims Elsevier charges "exorbitantly high" prices for its journals and criticises its practice of selling journals in "bundles" so libraries "must buy a large set with many unwanted journals, or none at all". It says the publisher makes "huge profits by exploiting their essential titles, at the expense of other journals".
The petition also criticises Elsevier's support for the
Stop Online Piracy Act (SOPA),
PIPA and the
US Research Works Act, which it says are an attempt to "restrict the free exchange of information".
"If you would like to declare publicly that you will not support any Elsevier journal unless they radically change how they operate, then you can do so by filling in your details in the box below," the petition says.
By Thursday afternoon, there were more than 3,000 names on the list – including academics from Oxford, Cambridge, Harvard and Yale universities, and the
Fields medal winners Timothy Gowers, Wendelin Werner and Terence Tao – and a host of critical comments.
No comments:
Post a Comment